Mercaptopurine FDA Link Generic

An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.

Also Known As:

6 Mercaptopurine; Purinethol; 6 Thiopurine; 1,7-Dihydro-6H-purine-6-thione; 6-Mercaptopurine Monohydrate; 6-Thiohypoxanthine; 6-Thiopurine; 6H-Purine-6-thione, 1,7-dihydro-; BW 57-323H; Leupurin; Mecaptopurine Anhydrous; Mercaptopurina Wellcome; Puri-Nethol; Purimethol; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; BW 57 323H; BW 57323H; 6-Mercaptopurine

Pharmalogical Action Categories:

Antimetabolites
Antimetabolites, Antineoplastic
Immunosuppressive Agents
Nucleic Acid Synthesis Inhibitors

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Sulfhydryl Compounds: 4168
    - Mercaptopurine: 1822
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Mercaptopurine: 1822

Maria Henthorn Selected Research

Maria Henthorn Research Topics

Disease

Drug/Important Bio-Agent (IBA)